Cardiac sodium channel inhibition by lamotrigine: In vitro characterization and clinical implications
Abstract Lamotrigine, approved for use as an antiseizure medication as well as the treatment of bipolar disorder, inhibits sodium channels in the brain to reduce repetitive neuronal firing and pathological release of glutamate. The shared homology of sodium channels and lack of selectivity associate...
Saved in:
Main Authors: | Lindsey Ingleby‐Talecki (Author), Sven C. vanDijkman (Author), Sean P. Oosterholt (Author), Oscar Della Pasqua (Author), Christina Winter (Author), Marianne Cunnington (Author), Linda Rebar (Author), Sergio Forero‐Schwanhaeuser (Author), Vickas Patel (Author), James A. Cooper (Author), Anthony Bahinski (Author), Khuram W. Chaudhary (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Lamotrigine on Nav1.4 Voltage-Gated Sodium Channels
by: Yoshihiko Nakatani, et al.
Published: (2013) -
Lamotrigine for Absence Seizures
by: J Gordon Millichap
Published: (1999) -
Effect of Lamotrigine on the EEG
by: J Gordon Millichap
Published: (2003) -
Anemia Associated with Lamotrigine
by: J Gordon Millichap
Published: (1997) -
Lamotrigine-Induced Aggressive Behavior
by: J Gordon Millichap
Published: (1998)